跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
POMOLIDE pomalidomide 3mg hard gelatin capsule blister - TGA Drug Approval Details
Approvals
/
TGA
/
POMOLIDE pomalidomide 3mg hard gelatin capsule blister
Approved
STANDARD
POMOLIDE pomalidomide 3mg hard gelatin capsule blister
Juno Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
cb0878b5cc01e774
Company
Juno Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
cb0878b5cc01e774
Product Name
POMOLIDE pomalidomide 3mg hard gelatin capsule blister
Artg Id
335280
Artg Name
POMOLIDE pomalidomide 3 mg hard gelatin capsule blister pack
Sponsor
Juno Pharmaceuticals Pty Ltd
Company Detail Path
/organization/juno-pharmaceuticals-pty-ltd
Artg Date
2021-05-18
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/133ca129a27e6206db1a74b1ce1a2f35.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/c50492ac3afd177767bdaa3edff18af5.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
cb0878b5cc01e774
Type
Standard
Back to TGA Approvals